Cyclopentenones containing a 4-(methylsulfonyl)phenyl group in the 3-positi
on and a phenyl ring in the 2-position are selective inhibitors of cyclooxy
genase-2 (COX-2). The selectivity for COX-2 over COX-1 is dramatically impr
oved by substituting the 2-phenyl group with halogens in the meta position
or by replacing the phenyl ring with a 2- or 3-pyridyl ring. Thus the 3,5-d
ifluorophenyl derivative 7 (L1776,967) and the 3-pyridyl derivative 13 (L-7
84,506) are particularly interesting as potential antiinflammatory agents w
ith reduced side-effect profiles. Both exhibit good oral bioavailability an
d are potent in standard models of pain, fever, and inflammation yet have a
much reduced effect on the GI integrity of rats compared to standard nonst
eroidal antiflammatory drugs.